Symbol:
Med13l
Name:
mediator complex subunit 13L
RGD ID:
1305884
Description:
Predicted to enable transcription coactivator activity. Predicted to be involved in positive regulation of transcription by RNA polymerase II. Predicted to be part of mediator complex. Human ortholog(s) of this gene implicated in dextro-looped transposition of the great arteries. Orthologous to human MED13L (mediator complex subunit 13L); PARTICIPATES IN RNA polymerase II transcription pathway; INTERACTS WITH 17beta-estradiol; 2,2',5,5'-tetrachlorobiphenyl; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC360817; mediator complex subunit 13-like; mediator of RNA polymerase II transcription subunit 13-like; Thrap2; thyroid hormone receptor associated protein 2; thyroid hormone receptor-associated 240-like protein
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 12 43,468,556 - 43,665,819 (-) NCBI GRCr8 mRatBN7.2 12 37,807,596 - 38,004,886 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 12 37,808,285 - 38,004,473 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 12 43,421,317 - 43,576,859 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 12 43,421,308 - 43,576,804 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 12 45,257,715 - 45,412,653 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 12 39,136,265 - 39,181,221 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 12 39,012,458 - 39,153,750 (-) NCBI Celera 12 39,469,893 - 39,630,500 (-) NCBI Celera Cytogenetic Map 12 q16 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Med13l Rat Au-Kline Syndrome ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Kabuki-like syndrome ClinVar PMID:25741868 Med13l Rat autism spectrum disorder ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Autism spectrum disorder ClinVar PMID:30504930 Med13l Rat Developmental Disabilities ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Global developmental delay ClinVar PMID:25712080|PMID:25741868|PMID:25741884|PMID:25758992|PMID:28492532|PMID:31785789 Med13l Rat dextro-looped transposition of the great arteries ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Transposition of the great arteries, dextro-looped ClinVar PMID:14638541|PMID:16199547|PMID:17576681|PMID:21937992|PMID:23403903|PMID:24267886|PMID:24781760|PMID:24896178|PMID:25137640|PMID:25167861|PMID:25356899|PMID:25712080|PMID:25741868|PMID:25741884|PMID:25758992|PMID:27824329|PMID:27899622|PMID:28371282|PMID:28492532|PMID:28554332|PMID:28588821|PMID:28645799|PMID:29159987|PMID:29346770|PMID:29511999|PMID:29959045|PMID:30564305|PMID:31144778|PMID:31171384|PMID:31618753|PMID:31785789|PMID:35982159|PMID:35982160|PMID:36135330|PMID:36798993|PMID:5167861|PMID:9536098 Med13l Rat genetic disease ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Inborn genetic diseases ClinVar PMID:12738880|PMID:14638541|PMID:23403903|PMID:24267886|PMID:24781760|PMID:24896178|PMID:25137640|PMID:25167861|PMID:25356899|PMID:25712080|PMID:25741868|PMID:25758992|PMID:27899622|PMID:28371282|PMID:28492532|PMID:28588821|PMID:28645799|PMID:29159987|PMID:29511999|PMID:31171384|PMID:5167861 Med13l Rat intellectual disability ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Intellectual disability ClinVar PMID:23403903|PMID:25167861|PMID:25741868|PMID:28492532|PMID:29511999 Med13l Rat Marfanoid Mental Retardation Syndrome, Autosomal ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Marfanoid habitus and intellectual disability ClinVar PMID:25741868 Med13l Rat Mental Retardation and Distinctive Facial Features with or without Cardiac Defects ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Cardiac anomalies - developmental delay - facial dysmorphism syndrome | more ... ClinVar PMID:14638541|PMID:17576681|PMID:22542183|PMID:23403903|PMID:24781716|PMID:24781760|PMID:24896178|PMID:25167861|PMID:25712080|PMID:25741868|PMID:25741869|PMID:25758992|PMID:26046367|PMID:27500536|PMID:28492532|PMID:28554332|PMID:28645799|PMID:28708303|PMID:29511999|PMID:29758562|PMID:30504930|PMID:31785789|PMID:35887114|PMID:35982159|PMID:35982160|PMID:36135330|PMID:36798993|PMID:39825153|PMID:9536098 Med13l Rat Neurodevelopmental Disorders ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Neurodevelopmental disorder ClinVar PMID:25712080|PMID:25741868|PMID:25758992|PMID:28492532|PMID:29959045 Med13l Rat strabismus ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Strabismus ClinVar PMID:25741868 Med13l Rat vesicoureteral reflux ISO RGD:1314183 8554872 ClinVar Annotator: match by term: Vesico-Ureteral Reflux ClinVar PMID:25741868
Only show annotations with direct experimental evidence (0 objects hidden)
Med13l Rat (-)-demecolcine increases expression ISO RGD:1314183 6480464 Demecolcine results in increased expression of MED13L mRNA CTD PMID:23649840 Med13l Rat (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1314183 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MED13L mRNA CTD PMID:22079256 Med13l Rat (1->4)-beta-D-glucan multiple interactions ISO RGD:1618275 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MED13L mRNA CTD PMID:36331819 Med13l Rat 1,2-dimethylhydrazine increases expression ISO RGD:1618275 6480464 1,2-Dimethylhydrazine results in increased expression of MED13L mRNA CTD PMID:22206623 Med13l Rat 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of MED13L mRNA CTD PMID:32145629 Med13l Rat 17beta-estradiol increases expression ISO RGD:1314183 6480464 Estradiol results in increased expression of MED13L mRNA CTD PMID:31614463 Med13l Rat 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2,5,2',5'-tetrachlorobiphenyl results in decreased expression of MED13L mRNA CTD PMID:23829299 Med13l Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1618275 6480464 Tetrachlorodibenzodioxin results in decreased expression of MED13L mRNA CTD PMID:17337447 Med13l Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MED13L mRNA CTD PMID:34747641 Med13l Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314183 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of MED13L mRNA CTD PMID:29704546 Med13l Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1618275 6480464 Tetrachlorodibenzodioxin affects the expression of MED13L mRNA CTD PMID:21570461|PMID:24680724 Med13l Rat 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1618275 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MED13L mRNA CTD PMID:20188158|PMID:26251327 Med13l Rat 3-methylcholanthrene multiple interactions ISO RGD:1314183 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to MED13L promoter] CTD PMID:20348232 Med13l Rat 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1,2-dithiol-3-thione results in decreased expression of MED13L mRNA CTD PMID:19162173 Med13l Rat 4,4'-sulfonyldiphenol decreases expression ISO RGD:1618275 6480464 bisphenol S results in decreased expression of MED13L mRNA CTD PMID:39298647 Med13l Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Med13l Rat 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1314183 6480464 bisphenol S results in decreased methylation of MED13L gene CTD PMID:31601247 Med13l Rat 5-fluorouracil multiple interactions ISO RGD:1314183 6480464 MED13L mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with more ... CTD PMID:16896004 Med13l Rat aflatoxin B1 decreases methylation ISO RGD:1314183 6480464 Aflatoxin B1 results in decreased methylation of MED13L gene CTD PMID:27153756 Med13l Rat aristolochic acid A decreases expression ISO RGD:1314183 6480464 aristolochic acid I results in decreased expression of MED13L mRNA; aristolochic acid I results in more ... CTD PMID:33212167 Med13l Rat arsane multiple interactions ISO RGD:1314183 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Med13l Rat arsenic atom multiple interactions ISO RGD:1314183 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Med13l Rat arsenite(3-) multiple interactions ISO RGD:1314183 6480464 arsenite inhibits the reaction [G3BP1 protein binds to MED13L mRNA] CTD PMID:32406909 Med13l Rat benzo[a]pyrene decreases expression ISO RGD:1314183 6480464 Benzo(a)pyrene results in decreased expression of MED13L mRNA CTD PMID:20064835 Med13l Rat benzo[a]pyrene decreases methylation ISO RGD:1618275 6480464 Benzo(a)pyrene results in decreased methylation of MED13L intron CTD PMID:27901495 Med13l Rat benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1314183 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MED13L mRNA CTD PMID:19150397 Med13l Rat benzo[e]pyrene decreases methylation ISO RGD:1314183 6480464 benzo(e)pyrene results in decreased methylation of MED13L intron CTD PMID:30157460 Med13l Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MED13L mRNA CTD PMID:25181051|PMID:32145629 Med13l Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Med13l Rat bisphenol A decreases expression ISO RGD:1618275 6480464 bisphenol A results in decreased expression of MED13L mRNA CTD PMID:38074096 Med13l Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MED13L mRNA CTD PMID:30816183|PMID:32528016|PMID:34947998 Med13l Rat bisphenol A decreases methylation ISO RGD:1618275 6480464 bisphenol A results in decreased methylation of MED13L promoter CTD PMID:27312807 Med13l Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... CTD PMID:36041667 Med13l Rat butanal decreases expression ISO RGD:1314183 6480464 butyraldehyde results in decreased expression of MED13L mRNA CTD PMID:26079696 Med13l Rat cadmium atom multiple interactions ISO RGD:1314183 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MED13L more ... CTD PMID:35301059 Med13l Rat cadmium dichloride multiple interactions ISO RGD:1314183 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MED13L more ... CTD PMID:35301059 Med13l Rat caffeine decreases phosphorylation ISO RGD:1314183 6480464 Caffeine results in decreased phosphorylation of MED13L protein CTD PMID:35688186 Med13l Rat carbamazepine affects expression ISO RGD:1314183 6480464 Carbamazepine affects the expression of MED13L mRNA CTD PMID:24752500 Med13l Rat chlorpyrifos decreases expression ISO RGD:1618275 6480464 Chlorpyrifos results in decreased expression of MED13L mRNA CTD PMID:37019170 Med13l Rat copper(II) sulfate increases expression ISO RGD:1314183 6480464 Copper Sulfate results in increased expression of MED13L mRNA CTD PMID:19549813 Med13l Rat coumarin increases phosphorylation ISO RGD:1314183 6480464 coumarin results in increased phosphorylation of MED13L protein CTD PMID:35688186 Med13l Rat crocidolite asbestos decreases expression ISO RGD:1314183 6480464 Asbestos, Crocidolite results in decreased expression of MED13L mRNA CTD PMID:29523930 Med13l Rat cyclophosphamide multiple interactions ISO RGD:1314183 6480464 MED13L mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with more ... CTD PMID:16896004 Med13l Rat cyclosporin A increases expression ISO RGD:1314183 6480464 Cyclosporine results in increased expression of MED13L mRNA CTD PMID:25562108 Med13l Rat Dibutyl phosphate affects expression ISO RGD:1314183 6480464 di-n-butylphosphoric acid affects the expression of MED13L mRNA CTD PMID:37042841 Med13l Rat diclofenac affects expression ISO RGD:1314183 6480464 Diclofenac affects the expression of MED13L mRNA CTD PMID:24752500 Med13l Rat dicrotophos increases expression ISO RGD:1314183 6480464 dicrotophos results in increased expression of MED13L mRNA CTD PMID:28302478 Med13l Rat dorsomorphin multiple interactions ISO RGD:1314183 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Med13l Rat doxorubicin multiple interactions ISO RGD:1314183 6480464 MED13L mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with more ... CTD PMID:16896004 Med13l Rat elemental selenium decreases expression ISO RGD:1314183 6480464 Selenium results in decreased expression of MED13L mRNA CTD PMID:19244175 Med13l Rat ethanol increases expression ISO RGD:1618275 6480464 Ethanol results in increased expression of MED13L mRNA CTD PMID:30319688 Med13l Rat fluoranthene multiple interactions ISO RGD:1618275 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of MED13L mRNA CTD PMID:28329830 Med13l Rat formaldehyde decreases expression ISO RGD:1314183 6480464 Formaldehyde results in decreased expression of MED13L mRNA CTD PMID:20655997 Med13l Rat FR900359 affects phosphorylation ISO RGD:1314183 6480464 FR900359 affects the phosphorylation of MED13L protein CTD PMID:37730182 Med13l Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MED13L mRNA CTD PMID:22061828|PMID:33387578 Med13l Rat glyphosate increases methylation EXP 6480464 Glyphosate results in increased methylation of MED13L gene CTD PMID:31011160 Med13l Rat GSK-J4 increases expression ISO RGD:1314183 6480464 GSK-J4 results in increased expression of MED13L mRNA CTD PMID:29301935 Med13l Rat hydrogen peroxide affects expression ISO RGD:1314183 6480464 Hydrogen Peroxide affects the expression of MED13L mRNA CTD PMID:20044591 Med13l Rat hydrogen peroxide multiple interactions ISO RGD:1314183 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of MED13L protein CTD PMID:18951874 Med13l Rat lead diacetate increases expression ISO RGD:1618275 6480464 lead acetate results in increased expression of MED13L mRNA CTD PMID:20542052 Med13l Rat leflunomide increases expression ISO RGD:1314183 6480464 leflunomide results in increased expression of MED13L mRNA CTD PMID:28988120 Med13l Rat manganese atom multiple interactions ISO RGD:1314183 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Med13l Rat manganese(0) multiple interactions ISO RGD:1314183 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Med13l Rat manganese(II) chloride multiple interactions ISO RGD:1314183 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Med13l Rat methapyrilene decreases methylation ISO RGD:1314183 6480464 Methapyrilene results in decreased methylation of MED13L intron CTD PMID:30157460 Med13l Rat methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of MED13L mRNA CTD PMID:30467583 Med13l Rat methotrexate increases expression ISO RGD:1314183 6480464 Methotrexate results in increased expression of MED13L mRNA CTD PMID:24449571 Med13l Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of MED13L gene CTD PMID:35440735 Med13l Rat methyl methanesulfonate increases expression ISO RGD:1314183 6480464 Methyl Methanesulfonate results in increased expression of MED13L mRNA CTD PMID:23649840 Med13l Rat methylmercury chloride decreases expression ISO RGD:1314183 6480464 methylmercuric chloride results in decreased expression of MED13L mRNA CTD PMID:28001369 Med13l Rat N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of MED13L gene CTD PMID:33148267 Med13l Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MED13L mRNA CTD PMID:25729387 Med13l Rat paclitaxel multiple interactions ISO RGD:1314183 6480464 MED13L mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with more ... CTD PMID:16896004 Med13l Rat panobinostat increases expression ISO RGD:1314183 6480464 panobinostat results in increased expression of MED13L mRNA CTD PMID:26272509 Med13l Rat panobinostat multiple interactions ISO RGD:1314183 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Med13l Rat perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1618275 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MED13L mRNA CTD PMID:36331819 Med13l Rat permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of MED13L gene CTD PMID:33148267 Med13l Rat phenobarbital affects expression ISO RGD:1314183 6480464 Phenobarbital affects the expression of MED13L mRNA CTD PMID:19159669 Med13l Rat phenylmercury acetate increases expression ISO RGD:1314183 6480464 Phenylmercuric Acetate results in increased expression of MED13L mRNA CTD PMID:26272509 Med13l Rat phenylmercury acetate multiple interactions ISO RGD:1314183 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Med13l Rat potassium chromate decreases expression ISO RGD:1314183 6480464 potassium chromate(VI) results in decreased expression of MED13L mRNA CTD PMID:22079256 Med13l Rat potassium chromate multiple interactions ISO RGD:1314183 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MED13L mRNA CTD PMID:22079256 Med13l Rat SB 431542 multiple interactions ISO RGD:1314183 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Med13l Rat selenium atom decreases expression ISO RGD:1314183 6480464 Selenium results in decreased expression of MED13L mRNA CTD PMID:19244175 Med13l Rat silver atom decreases expression ISO RGD:1618275 6480464 Silver results in decreased expression of MED13L mRNA CTD PMID:27131904 Med13l Rat silver(0) decreases expression ISO RGD:1618275 6480464 Silver results in decreased expression of MED13L mRNA CTD PMID:27131904 Med13l Rat sodium arsenite multiple interactions ISO RGD:1314183 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... CTD PMID:39836092 Med13l Rat sunitinib increases expression ISO RGD:1314183 6480464 Sunitinib results in increased expression of MED13L mRNA CTD PMID:31533062 Med13l Rat temozolomide increases expression ISO RGD:1314183 6480464 Temozolomide results in increased expression of MED13L mRNA CTD PMID:31758290 Med13l Rat theophylline multiple interactions ISO RGD:1314183 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of MED13L protein CTD PMID:18951874 Med13l Rat thimerosal increases expression ISO RGD:1314183 6480464 Thimerosal results in increased expression of MED13L mRNA CTD PMID:27188386 Med13l Rat thiram increases expression ISO RGD:1314183 6480464 Thiram results in increased expression of MED13L mRNA CTD PMID:38568856 Med13l Rat titanium dioxide increases methylation ISO RGD:1618275 6480464 titanium dioxide results in increased methylation of MED13L promoter CTD PMID:35295148 Med13l Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MED13L mRNA CTD PMID:25729387 Med13l Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of MED13L mRNA CTD PMID:25729387 Med13l Rat trichostatin A increases expression ISO RGD:1314183 6480464 trichostatin A results in increased expression of MED13L mRNA CTD PMID:24935251|PMID:26272509 Med13l Rat trichostatin A multiple interactions ISO RGD:1314183 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Med13l Rat triptonide increases expression ISO RGD:1618275 6480464 triptonide results in increased expression of MED13L mRNA CTD PMID:33045310 Med13l Rat troglitazone decreases expression ISO RGD:1618275 6480464 troglitazone results in decreased expression of MED13L mRNA CTD PMID:28973697 Med13l Rat troglitazone increases expression ISO RGD:1618275 6480464 troglitazone results in increased expression of MED13L mRNA CTD PMID:28973697 Med13l Rat tungsten decreases expression ISO RGD:1618275 6480464 Tungsten results in decreased expression of MED13L mRNA CTD PMID:30912803 Med13l Rat urethane increases expression ISO RGD:1314183 6480464 Urethane results in increased expression of MED13L mRNA CTD PMID:28818685 Med13l Rat valproic acid decreases expression ISO RGD:1314183 6480464 Valproic Acid results in decreased expression of MED13L mRNA CTD PMID:23179753 Med13l Rat valproic acid multiple interactions ISO RGD:1314183 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Med13l Rat valproic acid increases expression ISO RGD:1314183 6480464 Valproic Acid results in increased expression of MED13L mRNA CTD PMID:23179753|PMID:24935251|PMID:26272509 Med13l Rat valproic acid affects expression ISO RGD:1314183 6480464 Valproic Acid affects the expression of MED13L mRNA CTD PMID:25979313 Med13l Rat valproic acid decreases methylation ISO RGD:1314183 6480464 Valproic Acid results in decreased methylation of MED13L gene CTD PMID:29154799 Med13l Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MED13L mRNA CTD PMID:19015723 Med13l Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of MED13L mRNA CTD PMID:23034163 Med13l Rat vorinostat decreases expression ISO RGD:1314183 6480464 vorinostat results in decreased expression of MED13L mRNA CTD PMID:27188386 Med13l Rat zinc atom multiple interactions ISO RGD:1314183 6480464 [PCI 5002 co-treated with Zinc] results in decreased expression of MED13L mRNA CTD PMID:18593933 Med13l Rat zinc(0) multiple interactions ISO RGD:1314183 6480464 [PCI 5002 co-treated with Zinc] results in decreased expression of MED13L mRNA CTD PMID:18593933 Med13l Rat zoledronic acid decreases expression ISO RGD:1314183 6480464 zoledronic acid results in decreased expression of MED13L mRNA CTD PMID:20977926
(-)-demecolcine (ISO) (-)-epigallocatechin 3-gallate (ISO) (1->4)-beta-D-glucan (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (EXP,ISO) 2,2',5,5'-tetrachlorobiphenyl (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 3,4-methylenedioxymethamphetamine (ISO) 3-methylcholanthrene (ISO) 3H-1,2-dithiole-3-thione (EXP) 4,4'-sulfonyldiphenol (EXP,ISO) 5-fluorouracil (ISO) aflatoxin B1 (ISO) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) arsenite(3-) (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[e]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol F (EXP) butanal (ISO) cadmium atom (ISO) cadmium dichloride (ISO) caffeine (ISO) carbamazepine (ISO) chlorpyrifos (ISO) copper(II) sulfate (ISO) coumarin (ISO) crocidolite asbestos (ISO) cyclophosphamide (ISO) cyclosporin A (ISO) Dibutyl phosphate (ISO) diclofenac (ISO) dicrotophos (ISO) dorsomorphin (ISO) doxorubicin (ISO) elemental selenium (ISO) ethanol (ISO) fluoranthene (ISO) formaldehyde (ISO) FR900359 (ISO) gentamycin (EXP) glyphosate (EXP) GSK-J4 (ISO) hydrogen peroxide (ISO) lead diacetate (ISO) leflunomide (ISO) manganese atom (ISO) manganese(0) (ISO) manganese(II) chloride (ISO) methapyrilene (EXP,ISO) methotrexate (ISO) methoxychlor (EXP) methyl methanesulfonate (ISO) methylmercury chloride (ISO) N,N-diethyl-m-toluamide (EXP) oxaliplatin (EXP) paclitaxel (ISO) panobinostat (ISO) perfluorooctane-1-sulfonic acid (ISO) permethrin (EXP) phenobarbital (ISO) phenylmercury acetate (ISO) potassium chromate (ISO) SB 431542 (ISO) selenium atom (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sunitinib (ISO) temozolomide (ISO) theophylline (ISO) thimerosal (ISO) thiram (ISO) titanium dioxide (ISO) topotecan (EXP) trichostatin A (ISO) triptonide (ISO) troglitazone (ISO) tungsten (ISO) urethane (ISO) valproic acid (ISO) vinclozolin (EXP) vorinostat (ISO) zinc atom (ISO) zinc(0) (ISO) zoledronic acid (ISO)
Med13l (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 12 43,468,556 - 43,665,819 (-) NCBI GRCr8 mRatBN7.2 12 37,807,596 - 38,004,886 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 12 37,808,285 - 38,004,473 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 12 43,421,317 - 43,576,859 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 12 43,421,308 - 43,576,804 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 12 45,257,715 - 45,412,653 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 12 39,136,265 - 39,181,221 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 12 39,012,458 - 39,153,750 (-) NCBI Celera 12 39,469,893 - 39,630,500 (-) NCBI Celera Cytogenetic Map 12 q16 NCBI
MED13L (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 12 115,958,576 - 116,277,693 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 12 115,957,905 - 116,277,693 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 12 116,396,381 - 116,715,498 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 12 114,880,764 - 115,199,526 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 12 114,859,102 - 115,177,863 NCBI Celera 12 116,025,985 - 116,344,576 (-) NCBI Celera Cytogenetic Map 12 q24.21 NCBI HuRef 12 113,407,355 - 113,687,093 (-) NCBI HuRef CHM1_1 12 116,364,171 - 116,682,739 (-) NCBI CHM1_1 T2T-CHM13v2.0 12 115,939,568 - 116,258,754 (-) NCBI T2T-CHM13v2.0
Med13l (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 5 118,698,363 - 118,903,503 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 5 118,698,744 - 118,903,503 (+) Ensembl GRCm39 Ensembl GRCm38 5 118,560,330 - 118,765,438 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 5 118,560,679 - 118,765,438 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 5 119,010,728 - 119,215,447 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 5 118,821,773 - 119,024,010 (+) NCBI MGSCv36 mm8 Celera 5 115,689,167 - 115,861,251 (+) NCBI Celera Cytogenetic Map 5 F NCBI cM Map 5 59.1 NCBI
Med13l (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955455 14,679,416 - 14,957,532 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955455 14,679,416 - 14,960,226 (+) NCBI ChiLan1.0 ChiLan1.0
MED13L (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 10 124,015,884 - 124,335,362 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 12 124,012,262 - 124,331,735 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 12 113,531,181 - 113,850,854 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 12 116,906,557 - 117,187,192 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 12 116,909,244 - 117,065,649 (-) Ensembl panpan1.1 panPan2
MED13L (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 26 12,768,762 - 13,031,251 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 26 12,770,588 - 13,030,512 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 26 12,764,292 - 13,059,638 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 26 13,028,568 - 13,324,202 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 26 13,029,858 - 13,324,593 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 26 12,990,722 - 13,286,061 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 26 13,073,281 - 13,365,481 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 26 13,102,596 - 13,397,898 (-) NCBI UU_Cfam_GSD_1.0
Med13l (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405118 153,190,760 - 153,480,666 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936558 5,998,754 - 6,289,867 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936558 5,998,760 - 6,288,666 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
MED13L (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 14 36,063,644 - 36,383,800 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 14 36,061,834 - 36,384,567 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 14 38,298,853 - 38,578,678 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
MED13L (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 11 111,245,201 - 111,563,485 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 11 111,243,753 - 111,563,663 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666037 133,499,321 - 133,817,563 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Med13l (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 77 Count of miRNA genes: 70 Interacting mature miRNAs: 76 Transcripts: ENSRNOT00000042331 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
631560 Apr1 Acute phase response QTL 1 6.1 orosomucoid 1 amount (VT:0010541) plasma orosomucoid 1 level (CMO:0001467) 12 19144362 46669029 Rat 70213 Niddm27 Non-insulin dependent diabetes mellitus QTL 27 3.72 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 19835789 38193007 Rat 8552964 Pigfal17 Plasma insulin-like growth factor 1 level QTL 17 3.5 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564495 46669029 Rat 8693635 Alc28 Alcohol consumption QTL 28 2.7 0.439 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 12 23081340 44726024 Rat 7411641 Foco19 Food consumption QTL 19 27.7 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 7411643 Foco20 Food consumption QTL 20 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 20328819 46669029 Rat 61324 Eae5 Experimental allergic encephalomyelitis QTL 5 14 nervous system integrity trait (VT:0010566) percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time (CMO:0001402) 12 19610870 46669029 Rat 5684888 Pia42 Pristane induced arthritis QTL 42 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 19610870 42828880 Rat 1549912 Bp268 Blood pressure QTL 268 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 13182736 46669029 Rat 2302060 Pia37 Pristane induced arthritis QTL 37 6.1 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 12 13198157 46669029 Rat 9590147 Scort7 Serum corticosterone level QTL 7 13.61 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 12 1 42110980 Rat 1641928 Alcrsp5 Alcohol response QTL 5 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 12 12812385 46669029 Rat 1300162 Bp188 Blood pressure QTL 188 3.19 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 32103174 45899022 Rat 8552912 Pigfal6 Plasma insulin-like growth factor 1 level QTL 6 5 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564498 46669029 Rat 1549829 Scl48 Serum cholesterol level QTL 48 5 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 12 9603277 46669029 Rat 10059594 Kidm46 Kidney mass QTL 46 3.79 0.025 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 12 6107579 46669029 Rat 9590086 Insglur6 Insulin/glucose ratio QTL 6 18.97 0.001 blood insulin amount (VT:0001560) calculated plasma insulin level (CMO:0002170) 12 1 42110980 Rat 8552918 Pigfal7 Plasma insulin-like growth factor 1 level QTL 7 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 12 5564495 46669029 Rat 737822 Alc10 Alcohol consumption QTL 10 2.2 consumption behavior trait (VT:0002069) ethanol drink intake rate (CMO:0001407) 12 19610870 40218516 Rat 1549902 Bp269 Blood pressure QTL 269 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 13182736 46669029 Rat 1600386 Calcic2 Intracellular calcium level QTL 2 0.001 platelet physiology trait (VT:0005464) platelet intracellular calcium level (CMO:0000922) 12 28064433 46669029 Rat 1302792 Scl21 Serum cholesterol level QTL 21 3.8 0.0011 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 12 7196730 46669029 Rat 61404 Bw120 Body weight QTL 120 5.1 body mass (VT:0001259) body mass index (BMI) (CMO:0000105) 12 12351619 46669029 Rat 1556747 Calcic1 Intracellular calcium level QTL 1 3.6 platelet calcium amount (VT:0010500) platelet intracellular calcium level (CMO:0000922) 12 28064433 40130419 Rat 1300175 Cm5 Cardiac mass QTL 5 3.78 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 12 28064433 45899022 Rat 8693658 Alc33 Alcohol consumption QTL 33 2.1 0.68 drinking behavior trait (VT:0001422) calculated ethanol drink intake rate (CMO:0001615) 12 23081340 43551788 Rat 1331787 Rf41 Renal function QTL 41 2.998 kidney blood vessel physiology trait (VT:0100012) absolute change in renal blood flow rate (CMO:0001168) 12 28064557 40218380 Rat 2293699 Bss49 Bone structure and strength QTL 49 5.61 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra trabecular cross-sectional area (CMO:0001692) 12 10474137 46669029 Rat 1331761 Bp218 Blood pressure QTL 218 2.973 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 12 11073825 45055165 Rat 634351 Apr5 Acute phase response QTL 5 6.7 blood interleukin-6 amount (VT:0008595) plasma interleukin-6 level (CMO:0001927) 12 1 44503507 Rat 8694179 Bw150 Body weight QTL 150 2.9 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 12 1 42110980 Rat 634350 Apr4 Acute phase response QTL 4 6 orosomucoid 1 amount (VT:0010541) plasma orosomucoid 1 level (CMO:0001467) 12 1172005 46172005 Rat 7411545 Bw128 Body weight QTL 128 5.2 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 12 1 42110980 Rat 7411547 Bw129 Body weight QTL 129 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 6 5564495 46669029 Rat 737979 Pia22 Pristane induced arthritis QTL 22 53.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 12 1 44465750 Rat 2303569 Gluco44 Glucose level QTL 44 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 12 12812385 46669029 Rat 7411586 Foco5 Food consumption QTL 5 5.4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 2303575 Insul14 Insulin level QTL 14 4 blood insulin amount (VT:0001560) blood insulin level (CMO:0000349) 12 1 42450532 Rat 7411588 Foco6 Food consumption QTL 6 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 2302042 Pia38 Pristane induced arthritis QTL 38 3.5 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 12 1 44503507 Rat 2300186 Bmd59 Bone mineral density QTL 59 7.1 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 12 10474137 46669029 Rat 7411595 Foco9 Food consumption QTL 9 4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 7411597 Foco10 Food consumption QTL 10 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 5564495 46669029 Rat 7411660 Foco28 Food consumption QTL 28 10.9 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 12 1 42110980 Rat 631543 Bp83 Blood pressure QTL 83 5.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 12 15550826 38478808 Rat
RH143248
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 12 37,808,538 - 37,808,759 (+) MAPPER mRatBN7.2 Rnor_6.0 12 43,422,260 - 43,422,480 NCBI Rnor6.0 Rnor_5.0 12 45,258,658 - 45,258,878 UniSTS Rnor5.0 RGSC_v3.4 12 39,137,208 - 39,137,428 UniSTS RGSC3.4 Celera 12 39,470,836 - 39,471,056 UniSTS RH 3.4 Map 12 692.7 UniSTS Cytogenetic Map 12 q16 UniSTS
BI291178
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 12 37,809,800 - 37,809,991 (+) MAPPER mRatBN7.2 Rnor_6.0 12 43,423,522 - 43,423,712 NCBI Rnor6.0 Rnor_5.0 12 45,259,920 - 45,260,110 UniSTS Rnor5.0 RGSC_v3.4 12 39,138,470 - 39,138,660 UniSTS RGSC3.4 Celera 12 39,472,098 - 39,472,288 UniSTS RH 3.4 Map 10 583.6 UniSTS Cytogenetic Map 12 q16 UniSTS
AI717557
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 12 43,599,629 - 43,600,623 (+) Marker Load Pipeline mRatBN7.2 12 37,938,680 - 37,939,674 (+) MAPPER mRatBN7.2 Rnor_6.0 12 43,549,226 - 43,550,219 NCBI Rnor6.0 Rnor_5.0 12 45,385,647 - 45,386,640 UniSTS Rnor5.0 Celera 12 39,602,835 - 39,603,828 UniSTS RH 3.4 Map 12 701.5 UniSTS Cytogenetic Map 12 q16 UniSTS
BE116030
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 12 37,820,414 - 37,820,580 (+) MAPPER mRatBN7.2 Rnor_6.0 12 43,434,169 - 43,434,334 NCBI Rnor6.0 Rnor_5.0 12 45,270,567 - 45,270,732 UniSTS Rnor5.0 RGSC_v3.4 12 39,149,118 - 39,149,283 UniSTS RGSC3.4 Celera 12 39,483,334 - 39,483,499 UniSTS RH 3.4 Map 12 702.4 UniSTS Cytogenetic Map 12 q16 UniSTS
RH140782
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 12 37,809,205 - 37,809,348 (+) MAPPER mRatBN7.2 Rnor_6.0 12 43,422,927 - 43,423,069 NCBI Rnor6.0 Rnor_5.0 12 45,259,325 - 45,259,467 UniSTS Rnor5.0 RGSC_v3.4 12 39,137,875 - 39,138,017 UniSTS RGSC3.4 Celera 12 39,471,503 - 39,471,645 UniSTS RH 3.4 Map 12 703.4 UniSTS Cytogenetic Map 12 q16 UniSTS
BE119619
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 12 37,859,388 - 37,859,544 (+) MAPPER mRatBN7.2 Rnor_6.0 12 43,473,084 - 43,473,239 NCBI Rnor6.0 Rnor_5.0 12 45,309,482 - 45,309,637 UniSTS Rnor5.0 Celera 12 39,522,102 - 39,522,257 UniSTS RH 3.4 Map 12 695.9 UniSTS Cytogenetic Map 12 q16 UniSTS
AI717557
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 12 37,939,652 - 37,939,825 (+) MAPPER mRatBN7.2 Rnor_6.0 12 43,550,198 - 43,550,370 NCBI Rnor6.0 Rnor_5.0 12 45,386,619 - 45,386,791 UniSTS Rnor5.0 Celera 12 39,603,807 - 39,603,979 UniSTS RH 3.4 Map 12 701.5 UniSTS Cytogenetic Map 12 q16 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000042331 ⟹ ENSRNOP00000046404
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 37,808,285 - 37,966,245 (-) Ensembl Rnor_6.0 Ensembl 12 43,423,905 - 43,576,754 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000078445 ⟹ ENSRNOP00000073531
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 37,808,285 - 37,892,151 (-) Ensembl Rnor_6.0 Ensembl 12 43,421,308 - 43,503,456 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000081780 ⟹ ENSRNOP00000070275
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 37,808,285 - 37,966,328 (-) Ensembl Rnor_6.0 Ensembl 12 43,423,905 - 43,576,804 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000120071 ⟹ ENSRNOP00000092543
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 12 37,808,285 - 38,004,473 (-) Ensembl
RefSeq Acc Id:
NM_001419791 ⟹ NP_001406720
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 43,468,556 - 43,665,819 (-) NCBI mRatBN7.2 12 37,807,596 - 38,004,886 (-) NCBI
RefSeq Acc Id:
XM_039090172 ⟹ XP_038946100
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 43,468,556 - 43,665,425 (-) NCBI mRatBN7.2 12 37,807,596 - 38,004,485 (-) NCBI
RefSeq Acc Id:
XM_039090173 ⟹ XP_038946101
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 43,468,556 - 43,665,425 (-) NCBI mRatBN7.2 12 37,807,596 - 38,004,485 (-) NCBI
RefSeq Acc Id:
XM_039090175 ⟹ XP_038946103
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 43,468,556 - 43,665,262 (-) NCBI mRatBN7.2 12 37,807,596 - 38,004,320 (-) NCBI
RefSeq Acc Id:
XM_063271538 ⟹ XP_063127608
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 12 43,468,556 - 43,665,262 (-) NCBI
Ensembl Acc Id:
ENSRNOP00000073531 ⟸ ENSRNOT00000078445
Ensembl Acc Id:
ENSRNOP00000070275 ⟸ ENSRNOT00000081780
Ensembl Acc Id:
ENSRNOP00000046404 ⟸ ENSRNOT00000042331
RefSeq Acc Id:
XP_038946101 ⟸ XM_039090173
- Peptide Label:
isoform X2
- UniProtKB:
D4P4K6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038946100 ⟸ XM_039090172
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6AID1 (UniProtKB/TrEMBL), D4P4K6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038946103 ⟸ XM_039090175
- Peptide Label:
isoform X3
- UniProtKB:
A0A0G2K5R7 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000092543 ⟸ ENSRNOT00000120071
RefSeq Acc Id:
NP_001406720 ⟸ NM_001419791
- UniProtKB:
D4P4K6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063127608 ⟸ XM_063271538
- Peptide Label:
isoform X3
- UniProtKB:
A0A0G2K5R7 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2020-08-13
Med13l
mediator complex subunit 13L
Med13l
mediator complex subunit 13-like
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-03-07
Med13l
mediator complex subunit 13-like
Thrap2_predicted
thyroid hormone receptor associated protein 2 (predicted)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-01-12
Thrap2_predicted
thyroid hormone receptor associated protein 2 (predicted)
Symbol and Name status set to approved
70820
APPROVED